The effects of prognostic factors on transplant and mortality of patients with end-stage liver disease using Markov multistate model

被引:0
作者
Madreseh, Elham [1 ,2 ]
Mahmoudi, Mahmood [1 ]
Toosi, Mohssen Nassiri [3 ]
Abolghasemi, Jamileh [4 ]
Zeraati, Hojjat [1 ]
机构
[1] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran
[2] Univ Tehran Med Sci, Rheumatol Res Ctr, Tehran, Iran
[3] Univ Tehran Med Sci, Liver Transplantat Res Ctr, Imam Khomeini Hosp Complex, Tehran, Iran
[4] Iran Univ Med Sci, Sch Publ Hlth, Dept Biostat, Tehran, Iran
来源
JOURNAL OF RESEARCH IN MEDICAL SCIENCES | 2023年 / 28卷 / 01期
关键词
Cirrhosis; life expectancy; model for end-stage liver disease; survival; LONG-TERM SURVIVAL; WAITING-LIST; LIFE EXPECTANCY; MELD; RECIPIENTS; CIRRHOSIS; SCORE; BENEFIT; HEALTH; STATES;
D O I
10.4103/jrms.jrms_1091_21
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Decompensated cirrhosis patients have a high risk of death which can be considerably reduced with liver transplantation (LT). This study aimed to simultaneously investigate the effect of some patients' characteristics on mortality among those with/without LT and also LT incident.Materials and Methods: In this historical cohort study, the information from 780 eligible patients aged 18 years or older was analyzed by the Markov multistate model; they had been listed between 2008 and 2014, needed a single organ for initial orthotopic LT, and followed at least for up to 5 years.Results: With a median survival time of 6 (5-8) years, there were 275 (35%) deaths. From 255 (33%) patients who had LT, 55 (21%) subsequently died. Factors associated with a higher risk of mortality and LT occurrence were included: higher model for end-stage liver disease (MELD) score (hazard ratio [HR] = 1.16, confidence interval [CI]: 1.09-1.24 and HR = 1.22, CI: 1.41-1.30) and ascites complication (HR = 2.34, CI: 1.74-3.16 and HR = 11.43, CI: 8.64-15.12). Older age (HR = 1.03, CI: 1.01-1.06), higher creatinine (HR = 6.87, CI: 1.45-32.56), and autoimmune disease versus hepatitis (HR = 2.53, CI: 1.12-5.73) were associated with increased risk of mortality after LT.Conclusion: The MELD and ascites are influential factors on waiting list mortality and occurrence of LT. Total life expectancy is not influenced by higher MELD.
引用
收藏
页数:11
相关论文
共 55 条
  • [21] Institute for Health Metrics Evaluation, 2018, GBD COMP DAT VIS
  • [22] Jackson CH, 2011, J STAT SOFTW, V38, P1
  • [23] Jafarian A, 2014, ARCH IRAN MED, V17, P81, DOI 0141701/AIM.0012
  • [24] Long-term survival after liver transplantation in 4,000 consecutive patients at a single center
    Jain, A
    Reyes, J
    Kashyap, R
    Dodson, F
    Demetris, AJ
    Ruppert, K
    Abu-Elmagd, K
    Marsh, W
    Madariaga, J
    Mazariegos, G
    Geller, D
    Bonham, CA
    Gayowski, T
    Cacciarelli, T
    Fontes, P
    Starzl, TE
    Fung, JJ
    [J]. ANNALS OF SURGERY, 2000, 232 (04) : 490 - 498
  • [25] CARDIAC TRANSPLANTATION IN 150 PATIENTS AT STANFORD-UNIVERSITY
    JAMIESON, SW
    STINSON, EB
    SHUMWAY, NE
    [J]. BRITISH MEDICAL JOURNAL, 1979, 1 (6156) : 93 - 95
  • [26] A model to predict survival in patients with end-stage liver disease
    Kamath, PS
    Wiesner, RH
    Malinchoc, M
    Kremers, W
    Therneau, TM
    Kosberg, CL
    D'Amico, G
    Dickson, ER
    Kim, WR
    [J]. HEPATOLOGY, 2001, 33 (02) : 464 - 470
  • [27] Kleinbaum D.G., 2010, SURVIVAL ANAL
  • [28] Effect of Alcoholic Liver Disease and Hepatitis C Infection on Waiting List and Posttransplant Mortality and Transplant Survival Benefit
    Lucey, Michael R.
    Schaubel, Douglas E.
    Guidinger, Mary K.
    Tome, Santiago
    Merion, Robert M.
    [J]. HEPATOLOGY, 2009, 50 (02) : 400 - 406
  • [29] MELD as a metric for survival benefit of liver transplantation
    Luo, Xun
    Leanza, Joseph
    Massie, Allan B.
    Garonzik-Wang, Jacqueline M.
    Haugen, Christine E.
    Gentry, Sommer E.
    Ottmann, Shane E.
    Segev, Dorry L.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 (05) : 1231 - 1237
  • [30] Post Liver Transplantation Survival and Related Prognostic Factors among Adult Recipients in Tehran Liver Transplant Center; 2002-2019
    Madreseh, Elham
    Mahmoudi, Mahmood
    Nassiri-Toosi, Mohssen
    Baghfalaki, Taban
    Zeraati, Hojjat
    [J]. ARCHIVES OF IRANIAN MEDICINE, 2020, 23 (05) : 326 - 334